PPTA Europe

PPTA and the European Plasma Alliance (EPA) jointly welcome Hungary’s launch of its Donor Registry as a major step forward for donor safety, transparency, and compliance. Developed by the Hungarian National Blood and Transfusion Service (OVSZ), the registry strengthens trust in a safe, regulated plasma donation system and supports a reliable supply of life-saving plasma-derived medicines. This initiative also contributes to Europe’s goal of greater plasma self-sufficiency. Both PPTA and EPA remain committed to working with OVSZ, patients, and policymakers to protect donors and ensure patients across Europe can access the unique, lifesaving medicines they depend on. Read more in PPTA’s statement: https://lnkd.in/eH2-6Bv8

Ahead of #RareDiseaseDay next month, Micaela, a patient advocate with GBS|CIDP Foundation International shares advice that helped her embrace a rare disease diagnosis.

We're just 3 months away from Europe's leading Congress for the plasma community! The International Plasma Protein Congress (IPPC) is a commitment to the entire value chain of PDMPs – from vein to vein, from donor to patient. Participants will learn about European strategies for strengthening medical supply chains, global perspectives on improving patient access, and the essential role of dedicated healthy donors. When: 28-29 April Where: Milan, Italy Why: Insightful sessions, engaging discussions, and networking opportunities 🎟️ Registration is now open, sign up at pptaglobal.org/ippc to access early-bird rates!

Resilience. Reach. Responsibility. These three words with big impact were chosen as the theme of #IPPC2026 because they capture the realities facing the plasma community today. 🔄 Resilience reflects industry’s ability to adapt, innovate, and strengthen the plasma supply amid growing global demand and constant change. 🌍 Reach speaks to the industry’s expanding global footprint and our commitment to working with partners to increase patient access to life-saving therapies around the world. 🫶 Responsibility remains foundational for the field and encompasses safety, quality, and awareness for donors, patients, and communities alike. Together, these “three Rs” highlight the importance of the broader and evolving plasma ecosystem. No single organization can meet patient need alone; progress depends on collaboration across industry, regulators, health care partners, and patient communities. We each support a vital part of a high-performing global network dedicated to access and advocacy. This year’s IPPC programming will reflect the theme, as sessions will showcase not only how we can efficiently, effectively, and safely advance the plasma supply, but how we can serve as a model and partner for others working toward the same goal meeting patient need, now and into the future. Check out this year’s program to learn more. Additional details will be released soon: https://bit.ly/43LEljj #ResilienceReachResponsibility

📖 Europe's leading Congress for the plasma community is back this April in Milan, Italy! The International Plasma Protein Congress (IPPC) is a commitment to the entire value chain of PDMPs – from vein to vein, from donor to patient. 💡 Through insightful sessions, engaging discussions, and networking opportunities, participants will learn about European strategies for strengthening medical supply chains, global perspectives on improving patient access, and the essential role of dedicated healthy donors. 🎟️ Registration is now open, sign up at pptaglobal.org/ippc to access early-bird rates!

There’s plenty to see in Milan, Italy, while in town for #IPPC2026. Make time in your itinerary for an exciting trip following eventful sessions by plasma industry experts, leaders, and advocates. Registration for IPPC opens on Monday! Visit pptaglobal.org/ippc to learn more. #ResilienceReachResponsibility

Registration for #IPPC2026 kicks off in less than a week! Be sure to visit pptaglobal.org/ippc on 26 January to secure your spot, connect with industry professionals, and stay informed about the latest advancements in the plasma industry. #ResilienceReachResponsibility

A strong plasma supply is a cornerstone of modern, resilient health care systems. Plasma-derived medicines are critical for treating rare and chronic diseases, and also play a role in emergency and critical care. Donations are critical for making these unique treatments possible. 🛡️ Local plasma collection strengthens European health security 🔄 Supply security reduces vulnerability to shortages during health crises 🤝 A reliable plasma supply makes resilience possible 👉 Health care resilience prepares Europe for tomorrow Find out more: euneedsmoreplasma.com

PPTA welcomes the adoption of the European Parliament’s position on the Critical Medicines Act (CMA). By directly recognising the diversity of pharmaceutical supply chains within the scope of the Act, CMA’s framework, updated by the Parliament, is strengthening supply security and improving patient access across the EU. With trilogue negotiations ahead, PPTA urges the Council and the European Commission to align with Parliament’s approach and ensure that the Regulation captures the real-world complexities relevant to plasma-derived medicines. Parallelly, PPTA calls for keeping patients' access at the heart of EU policy, since unilateral and uncoordinated national stockpiling risks disrupting an already limited PDMP supply and can unintentionally undermine what CMA aims to protect. This is why PPTA recommends avoiding national stockpiling and limiting EU-level stockpiling to only clearly defined crisis situations. For more details, check the statement published right after the SANT Committee voting in December: https://lnkd.in/eW9xACkG